Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000730128 | SCV000857843 | uncertain significance | not provided | 2017-10-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004026987 | SCV003759126 | uncertain significance | not specified | 2022-07-12 | criteria provided, single submitter | clinical testing | The c.562G>A (p.V188M) alteration is located in exon 2 (coding exon 1) of the GPBAR1 gene. This alteration results from a G to A substitution at nucleotide position 562, causing the valine (V) at amino acid position 188 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003947923 | SCV004762168 | likely benign | GPBAR1-related disorder | 2021-12-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |